Friedland Jeffrey 4
4 · Intiva BioPharma Inc. · Filed Nov 30, 2017
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Other
Common Stock
2017-11-29+130,859→ 208,000 total(indirect: By LLC) - Other
Class C Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (20,800 underlying) - Other
Class B Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (20,800 underlying) - Other
Common Stock
2017-11-29+15,099,083→ 24,000,000 total(indirect: By Intiva USA Inc.) - Other
Common Stock
2017-11-29+1,258,257→ 2,000,000 total - Other
Class A Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.25From: 2017-11-29Exp: 2018-01-31→ Common Stock (20,800 underlying)
Footnotes (7)
- [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
- [F2]Acquired in exchange for all of Intiva USA's shares of Intiva BioPharma Inc.
- [F3]Acquired in exchange for all of Jeffrey Friedland's shares of Intiva BioPharma Inc.
- [F4]Acquired in exchange for all of Lane 6552 LLC's shares of Intiva BioPharma Inc.
- [F5]Acquired in exchange for all of Lane 6552 LLC's Class A warrants of Intiva BioPharma Inc.
- [F6]Acquired in exchange for all of Lane 6552 LLC's Class B warrants of Intiva BioPharma Inc.
- [F7]Acquired in exchange for all of Lane 6552 LLC's Class C warrants of Intiva BioPharma Inc.